Clinical Research Directory
Browse clinical research sites, groups, and studies.
RCT for the Chinese Medicine in Treating Hypercholesterolemia
Sponsor: Chinese University of Hong Kong
Summary
This is a randomized, double-blind, placebo-controlled clinical trial. Eligible subjects will randomized into a treatment group or placebo group. They will receive either Chinese medicine granules or placebo granules for 8 weeks followed by a 4-week observation period. The primary outcome would be the percent change in Low-density lipoprotein cholesterol levels (LDL-C) after treatment.
Official title: Efficacy and Safety of Dachaihu Decoction Combined Erzhiwan With Variation for the Treatment of Hypercholesterolemia: A Parallel, Randomized, Double-blinded, Placebo-controlled Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-01
Completion Date
2027-04
Last Updated
2024-11-22
Healthy Volunteers
No
Conditions
Interventions
Dachaihu Decoction combined Erzhiwan with variation
Chinese medicine granules
Placebo granules
Placebo granules